Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3939-12-6 | MDL No. : | MFCD09261087 |
Formula : | C6H3FN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VRLVOMUVHHHJHB-UHFFFAOYSA-N |
M.W : | 122.10 g/mol | Pubchem ID : | 15765964 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 28.91 |
TPSA : | 36.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.33 cm/s |
Log Po/w (iLOGP) : | 1.25 |
Log Po/w (XLOGP3) : | 1.0 |
Log Po/w (WLOGP) : | 1.51 |
Log Po/w (MLOGP) : | 0.22 |
Log Po/w (SILICOS-IT) : | 1.76 |
Consensus Log Po/w : | 1.15 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.72 |
Solubility : | 2.32 mg/ml ; 0.019 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.36 |
Solubility : | 5.34 mg/ml ; 0.0437 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.34 |
Solubility : | 0.554 mg/ml ; 0.00454 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.81 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With ammonia; hydrogen In methanol at 20℃; for 12 h; | 6-fluoro-3-cyanopyridine (300 mg, 2.46 mmol)Dissolved in 2 mol / L ammonia / methanol solution (30 mL),Add Raney nickel (0.5g),H2 atmosphere at room temperature for 12 hours.After the reaction, the reaction solution was filtered through diatomaceous earth,Methanol rinse (5 mL x 2),The filtrate is evaporated to dryness,The residue was purified by silica gel column chromatography (dichloromethane: methanol = 100: 4)To give 262 mg of a yellow oily solid,The yield was 85percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With N-ethyl-N,N-diisopropylamine; In propan-1-ol; at 150℃; for 2h; | A heavy-walled, screw-cap glass tube was charged with (R)-tert-butyl 3- aminopyrrolidine-1-carboxylate (3.30 g, 17.7 mmol), <strong>[3939-12-6]2-fluoro-5-cyanopyridine</strong> (1.63 g, 13.2 mmol), J-Pr2NEt (6.3 mL, 35.5 mmol) and n-PrOH (3 mL). The mixture was heated at 150 0C in an oil bath for 2 h. The mixture was diluted with EtOAc (180 mL), washed with 1 percent aq HCI (3 x 40 mL), satd aq NaHCO3 (40 mL) and brine (40 mL), and dried over Na2SO4. Removal of the solvent left an oil (3.28 g) which was purified by chromatography on a 40-g silica gel cartridge eluted with a 0-100percent EtOAc in hexanes gradient to afford (R)-tert-butyl 3-(5-cyanopyridin-2-ylamino)pyrrolidine-1- carboxylate (3.41 g, 88percent based on <strong>[3939-12-6]2-fluoro-5-cyanopyridine</strong>). LC-MS Method 1 tR = 1.57 min, m/z = 289. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate; In dimethyl sulfoxide; acetone; at 20 - 55℃;Inert atmosphere; | 6-((6-(2-(2,4-difluorophenyl)-l,l-difluoro-2-hydroxy-3-(lH-tetrazol-l-yl)propyl)pyridin- 3-yl)methoxy)nicotinonitrile (98)To a magnetically stirred mixture of (6-((2-(2,4-difluorophenyl)oxiran-2- yl)difluoromethyl)pyridin-3-yl)methanol (BU from Example 53; 156 mg, 0.498 mmol) in Acetone (2.490 mL) was added K2C03 (138 mg, 0.996 mmol) in a dry 25 mL vial under N2 atmosphere. <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (73.0 mg, 0.598 mmol) was added and the reaction mixture was stirred at RT for 2 hours, but no reaction progress was noted. DMSO (1 mL) was added, and the reaction mixture was stirred at RT overnight. HPLC-MS indicated the reaction was -50percent complete. The reaction mixture was heated to 55°C for 6 hours, at which point, TLC and HPLC-MS indicated the reaction was mostly complete. The crude material was diluted with ice-water and ether and the layers were separated. The aq. layer was extracted again with ether, and the combined ether extracts were dried over sodium sulfate, filtered, and evaporated. The crude residue was purified on silica (40 gram column, gradient to 20percent EA/Hex over 15 minutes, hold for 20 minutes) to afford compound BZ. Yield = 200 mg (92 percent) of a white waxy solid, .H NMR (400 MHz, CDCI3) delta 8.75 (s, 1H), 8.49 (dd, J = 2.4, 0.6 Hz, 1H), 7.84 (dd, J = 8.7, 2.4 Hz, 2H), 7.51 (d, J = 8.0 Hz, 1H), 7.39 (dd, J = 14.7, 8.2 Hz, 1H), 6.91 (dd, J = 8.7, 0.6 Hz, 1H), 6.84 (ddd, J = 7.8, 2.4, 1.3 Hz, 1H), 6.78 - 6.70(m, 1H), 5.51 (s, 2H), 3.44 (d, J = 5.0 Hz, 1H), 3.01 - 2.94 (m, 1H). .H-decoupled NMR (376 MHz, CDCI3) delta -107.07 (d, J = 9.5 Hz), -107.54 (d, J = 9.5 Hz), -107.75 (d, J = 8.2 Hz), - 107.98 (d, J = 8.2 Hz), - 108.67 (d, J = 8.2 Hz), -109.35 (dd, J = 17.7, 9.5 Hz). MS (ESI): m/z 416.9 (M+H)+.To a magnetically stirred mixture of 6-((6-((2-(2,4-difluorophenyl)oxiran-2- yl)difluoromethyl)pyridin-3-yl)methoxy)nicotinonitrile (BZ; 200 mg, 0.482 mmol) and 1H- tetrazole (67.5 mg, 0.963 mmol) in dry DMF (4.815 mL) was added K2C03 (133 mg, 0.963 mmol) in a dry 25 mL vial under N2 atmosphere. The reaction mixture was stirred at 55 °C for 36 hours, then cooled to RT, and diluted with ice-water and ether. The layers were separated and the aq. layer was extracted again with ether (2x). The combined ether extracts were dried over sodium sulfate, filtered, and evaporated. The crude residue was purified on silica (40 gram column, gradient over 15 min to 40percent EA/Hex, hold 10 min then 10 min at 80percent EA/hex, monitor 240 and 254 nm). The respective product fractions were evaporated to afford the title compound contaminated with DMF. The material was diluted with water and extracted 3x with ether, the combined ether extracts were diluted with pet. ether and washed with sat'd NH4CI (2x) and brine (lx), dried over MgS04, filtered, and evaporated to afford98. Yield = 62 mg (25.2 percent) of a white foam, .H NMR (400 MHz, CDCI3) delta 8.75 (s, 1H), 8.63 (d, J = 1.3 Hz, 1H), 8.48 (dd, J = 2.3, 0.8 Hz, 1H), 7.91 (dd, J = 8.2, 2.1 Hz, 1H), 7.85 (dd, J = 8.7, 2.4 Hz, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.56 (s, 1H), 7.35 (td, J = 9.0, 6.5 Hz, 1H), 6.92 (dd, J = 8.5, 0.8 Hz, 1H), 6.76 (ddd, J = 12.0, 8.5, 2.5 Hz, 1H), 6.71 - 6.61 (m, 1H), 5.56(d, J = 14.3 Hz, 1H), 5.50 (s, 2H), 5.13 (dd, J = 14.2, 1.1 Hz, 1H). .H-decoupled ^F NMR (376 MHz, CDCI3) delta -103.83 (ddd, J = 42.2, 17.0, 10.2 Hz), - 104.20 (d, J = 16.3 Hz), - 104.89 (d, J = 16.3 Hz), -107.90 - 108.07 (m), - 110.92 (dd, J = 262.9, 42.2 Hz). MS (ESI): m/z 486.1 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydroxyquinone; hydroxylamine hydrochloride; potassium carbonate; In ethanol; water; for 4h;Reflux; | A solution of <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (1.00 g, 8.19 mmol) in EtOH (14 mL) was treated with an excess of hydroxylamine hydrochloride (1.195 g, 17.2 mmol) and 1.81 g (13.1 mmol) of potassium carbonate dissolved in 14 mL of water. A catalytic amount of 8-hydroxyquinone (0.015 g, 0.106 mmol) was added and the resulting solution was stirred at reflux for 4 h. Most of the ethanol was removed under reduced pressure and the aqueous residue was extracted with ethyl acetate. The combined organic layers were washed with brine and concentrated to give the product as an orange solid (1.53 g, 7.43 mmol, 91percent yield), which was used without purification for the next step. 'H NMR (400 MHz, DMSO-d6) delta ppm 9.84 (s, 1 H) 8.51 (d, J=2.45 Hz, 1 H) 8.21 (td, J=8.25, 2.57 Hz, 1 H) 7.21 (dd, J=8.56, 2.93 Hz, 1 H) 6.01 (s, 2 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1-methyl-pyrrolidin-2-one; N-ethyl-N,N-diisopropylamine; at 20 - 100℃; for 4h;Microwave irradiation; | General procedure: (i?)-6-(l-(2-Hvdroxy-2-(4-methyl-l-oxo-l,3-dihvdroisobenzofuran-5-yl)ethyl)piperidin-4- ylamino)nicotinonitrile To a mixture of (i?)-5-(2-(4-aminopiperidin-l-yl)-l -hydroxy ethyl)-4-methylisobenzofuran- l(3H)-one hydrochloride (60 mg, 0.16 mmol) and <strong>[3939-12-6]5-cyano-2-fluoropyridine</strong> (20 mg, 0.16 mmol) in N-methylpyrolidinone (550 mu) was added DIEA (57 mu, 0.33 mmol) in a microwave tube at room temperature. The tube was sealed and heated at 100°C for 4 h. The mixture was cooled and partitioned between EtOAc/hexanes (2: 1) and water. The aqueous layer was extracted with EtOAc (2x). The combined organic phase was washed with brine, dried (MgS04), filtered and concentrated. The resulting residue was purified by prep TLC (silica gel, 10percent MeOH/DCM) to provide (R)-6-(l -(2-hydroxy-2-(4-methyl- 1 -oxo- 1 ,3-dihydroisobenzofuran-5-yl)ethyl)piperidin- 4-ylamino)nicotinonitrile. 1H-NMR (CDC13, 500 MHz), delta 8.39 (m, 1H), 7.82 (s, 2H), 7.60 (m, 1H), 6.41 (m, 1H), 5.29 (s, 2H), 4.92 (m, 1H), 3.23 (m, 1H), 2.96 (m, 1H), 2.39-2.46 (m, 4H), 2.18 (s, 3H), 2.02 (m, 4H); LC-MS (IE, m/z): 393 [M + 1]+. | |
With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 100℃; for 4h;Sealed tube; | [0538] To a mixture of (R)-5-(2-(4-aminopiperidin-1-yl)-1-hydroxyethyl)-4-methylisobenzofuran-1(3H)-one hydrochloride(60 mg, 0.16 mmol) and <strong>[3939-12-6]5-cyano-2-fluoropyridine</strong> (20 mg, 0.16 mmol) in N-methylpyrolidinone (550 ml) was addedDIEA (57 ml, 0.33 mmol) in a microwave tube at room temperature. The tube was sealed and heated at 100°C for 4 h.The mixture was cooled and partitioned between EtOAc/hexanes (2:1) and water. The aqueous layer was extractedwith EtOAc (2x). The combined organic phase was washed with brine, dried (MgSO4), filtered and concentrated. Theresulting residue was purified by prep TLC (silica gel, 10percent MeOH/DCM) to provide (R)-6-(1-(2-hydroxy-2-(4-methyl-1-oxo-1,3-dihydroisobenzofuran-5-yl)ethyl)piperidin-4-ylamino)nicotinonitrile. 1H-NMR (CDCl3, 500 MHz), delta 8.39 (m, 1H),7.82 (s, 2H), 7.60 (m, 1H), 6.41 (m, 1H), 5.29 (s, 2H), 4.92 (m, 1H), 3.23 (m, 1H), 2.96 (m, 1H), 2.39-2.46 (m, 4H), 2.18(s, 3H), 2.02 (m, 4H); LC-MS (IE, m/z): 393 [M + 1]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydrogencarbonate; In dimethyl sulfoxide; at 110℃; | Intermediate 43 methyl 3-((l-(5-cvanopyridin-2-yl')piperidin-4-yl oxy -2,2-dimethylpropanoate A mixture of <strong>[3939-12-6]6-fluoropyridine-3-carbonitrile</strong> (1.2 g, 9.83 mmol), methyl 2,2-dimethyl-3- (piperidin-4-yloxy)propanoate (3.81 g, 8.85 mmol) and NaHC03 (16.51 g, 197 mmol) inDMSO (19.66 ml) was heated at 110°C overnight. The reaction was cooled to RT, quenched with water, and extracted with EtOAc. The organic layers were washed with brine, dried (Na2S04), and concentrated. The residue was purified by MPLC eluted with 10percent EtOAc in hex to EtOAc to afford methyl 3-((l-(5-cyanopyridin-2-yl)piperidin-4-yl)oxy)-2,2-dimethylpropanoate. LC-MS (ES, m/z) C17H23N303: 317; Found: 318 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51% | With sodium hydrogencarbonate; In dimethyl sulfoxide; at 110℃;Inert atmosphere; | Intermediate 55 2-(trans-4-(l-("5-cvanopyridin-2-yl piperidin-4-yloxy)cyclohexynacetic acid A mixture of 2-(trans-4-(piperidin-4-yloxy)cyclohexyl)acetic acid (800 mg, 3.32 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (405 mg, 3.32 mmol), and sodium bicarbonate (1.67 g, 19.9 mmol) are suspended in DMSO (6 ml), the reaction mixture was stirred over night at 110°C under N2 in an oil bath. The reaction mixture was cooled to room temperature, and concentrated under vacuum. Then applied onto a silica gel column and eluted with Acetone/DCM 0-80percent. This resulted in 0.58 g (51percent) of 2-(trans-4-(l-(5-cyanopyridin-2-yl)piperidin-4-yloxy)cyclohexyl)acetic acid as a white solid. LC-MS (ES, m/z) C19H25N303: 343; Found: 344 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydrogencarbonate; In dimethyl sulfoxide; at 110℃; | Intermediate 63 2-(4-( 1 -(5-cvanopyridin-2-yl)piperidin-4-yl phenyl acetic acid To commercially available 2-(4-(piperidin-4-yl)phenyl)acetic acid (0.7 g, 2.74 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (0.334 g, 2.74 mmol) in DMSO (6.84 ml) was added sodium bicarbonate (1.380 g, 16.42 mmol) and the reaction was stirred at 110 °C overnight. The reaction was cooled to rt and acidified with IN HCl (aq.) to pH 2 and lyophilized. The residue was purified by MPLC (0-100percent acetone in DCM) to give 0.71 g solid (not pure), which was purified by prep HPLC (Instrument: Shimadzu LC-20AP Prep HPLC; Column: Synergi C18 lOu, 250x50mm I.D.; Mobile phase: A for H20 0.1percentTFA and B for Acetonitrile 0.1percentTFA; Gradient: B 20percent-50percent in 30min linearly; Flow rate: 80ml/min; Sample preparation: dissolved in Acetonitrile, lOOmg/ml ; Injection: 3ml per injection.) After HPLC, The fraction was concentrated to remove the organic phases via rotary evaporator at bath temperature 35°C. The material was lyophilized to give 2-(4- (l-(5-cyanopyridin-2-yl)piperidin-4-yl)phenyl)acetic acid. LC-MS (ES, m/z) C19H19N30 : 321; Found: 322 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
32% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 0.5h;Microwave irradiation; | A solution of rac- I -((2S,3R,4R)-4-am ino-6-fluoro-2,3-dimethyl-3,4-dihyd roquinolin- I (2H)-yl)ethanone (for a preparation see Intermediate 143, 90 mg, 0.381 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (93 mg, 0.762 mmol) and DIPEA (0.133 ml, 0.762 mmol) in NMP (1 mL) was heated in the microwave at 200°C for 30 mm. The solution was directly purified by MDAP (Formic). The appropriate fractions were combined and concentrated in vacuo to give the title compound (41 mg, 0.121 mmol, 32percent). LCMS (2 mm Formic): Rt = 0.91 mi [MH] = 339. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52.5% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 1h;Microwave irradiation; | The rac- I -((2S,3R,4R)-4-am ino-2-cyclopropyl-6-fluoro-3-methyl-3,4-dihyd roquinolin- I (2H)- yl)ethanone (for a preparation see Intermediate 146, 100 mg, 0.381 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (93mg, 0.762 mmol), DIPEA (0.133 mL, 0.762 mmol) and N-methyl-2-pyrrolidone (NMP) (2 mL) were irradiated in a microwave at 200 °C for I h. The reaction was purified directly using a MDAP (Formic) to give a solid. This solid was eluted through a NH2 SPE (5 g) with MeOH, the eluent was concentrated and dried to give the product (73 mg, 0.200 mmol, 52.5percent) as an off-white solid. LCMS (2 mm Formic): Rt = 1.00 mi [MH] = 365. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70 mg | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 150℃; for 1h;Inert atmosphere; Microwave irradiation; | A solution of rac- I -((2S ,3R,4R)-4-amino-6-(3,6-dihyd ro-2H-pyran-4-yl)-2,3-dimethyl-3,4- dihydroquinolin-1(2H)-yl)ethanone (for a preparation see Intermediate 150, 101 mg, 0.336 mmol) in NMP (1 mL) was treated with DIPEA (0.061 mL, 0.350 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (43 mg,0.352 mmol) then heated at 150 °C for 1 h using a microwave reactor. Crude product was purified directly by MDAP (HpH) and appropriate fractions combined then concentrated under reduced pressure to give the desired product as a white foamy solid (70 mg).LCMS (2 mm Formic): Rt = 0.93 mi [MH] = 403. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
17 mg | With N-ethyl-N,N-diisopropylamine; at 200℃; for 0.5h;Microwave irradiation; | To a microwave vial <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (30.3 mg, 0.248 mmol), rac-1-((2S,3R,4R)-4-amino-2,3- dimethyl-6-(tetrahydro-2H-pyran-4-yl)-3,4-dihyd roquinolin- I (2H)-yl)ethanone (for a preparation see Intermediate 152, 37.5 mg, 0.124 mmol), and DIPEA (0.065 mL, 0.372 mmol) were added and the reaction heated to 200 °C in a microwave reactor for 30 minutes. The reaction mixture was diluted to2 ml with methanol and purified in 2 batches by MDAP (Formic). The clean fractions from both runs were combined and the solvent was evaporated in vacuo to give 21 mg of product as a yellow solid. This was dissolved in methanol and run through a pre-equilibrated -NH2 column (5 g) in order to form the free base. The methanol was evaporated in vacuo to give 17 mg of product.LCMS (2 mm Formic): Rt = 0.91 mi [MH] = 405. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25.8% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 0.5h;Microwave irradiation; | A solution of rac-tert-butyl 4-((2S,3R,4R)- I -acetyl-4-amino-2,3-dimethyl- I ,2,3,4-tetrahydroq uinolin-6- yl)piperidine-I-carboxylate (for a preparation see Intermediate 157, 65 mg, 0.162 mmol), 6- fluoronicotinonitrile (39.5 mg, 0.324 mmol), and DIPEA (0.057 mL, 0.324 mmol) in N-methyl-2-pyrrolidone (NMP) (1 .5 mL) was heated in a microwave at 200 °C for 30 mm. The reaction mixture was purified directly by MDAP (Formic). The appropriate fractions were combined and concentrated in vacuo to give the product (21 mg, 0.042 mmol, 25.8percent yield).LCMS (2 mm Formic): Rt = 1.15 mi [MH] = 504. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 150℃; for 1h;Microwave irradiation; | A 0.5-2 mL microwave vial was evacuated and back filled with N2. rac-tert-Butyl 4-((2S,3R,4R)-I-acetyl-4-am ino-2-ethyl-3-methyl- I ,2,3,4-tetrahydroq uinolin-6-yl)piperazine- I -carboxylate (for apreparation see Intermediate 172, 37 mg, 0.089 mmol) in N-methyl-2-pyrrolidone (NMP) (I mL) was then added. To this was added <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (21.69 mg, 0.178 mmol), and DIPEA (0.047and concentrated in vacuo to afford the desired product as a brown gum (26.6 mg, 0.051 mmol, mL, 0.266 mmol) and the resultant solution then heated to 150 °C for 30 mm in a microwave. The reaction was then reheated to 150 °C for 30 mm. The reaction mixture was filtered through a cotton wool plug directly into two LCMS vials and was then purified by 2xMDAP (Formic). The appropriate fractions were collected and concentrated in vacuo to afford the desired product as a brown gum(16.6 mg, 0.032 mmol, 36.0percent). LCMS (2 mm Formic): Rt= 1.12 mi [MH] 519. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43.9% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 0.5h;Microwave irradiation; | To a reaction vessel <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (64.8 mg, 0.531 mmol), rac-(2S,3R,4R)- I -acetyl-4-amino-2-cyclopropyl-N,3-dimethyl- I ,2,3,4-tetrahydroqu inoline-6-carboxamide (for preparation seeIntermediate 200, 80 mg, 0.265 mmol) and DIPEA (0.139 mL, 0.796 mmol) were added and thereaction irradiated in a microwave at 200 °C for 30 mm. The reaction was purified directly by MDAP(Formic) to give a crude solid. This solid was purified by MDAP (Formic) to give a solid which was eluted through a NH2 SPE (5 g) with MeOH, the eluent was concentrated to the product (47 mg, 0.116 mmol, 43.9percent) as a white solid. LCMS (2 mm Formic): Rt = 0.80 mi [MH] = 404. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With triethylamine; In N,N-dimethyl-formamide; at 150℃; for 2.5h; | A solution of I -((2S,3R,4R)-4-am ino-2-cyclopropyl-6-fluoro-3-methyl-3,4-dihyd roquinolin- I (2H)-yl)ethanone (for a preparation see Intermediate 332, 150 mg, 0.572 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong>(140 mg, 1.144 mmol) and triethylamine (0.159 mL, 1.144 mmol) in N,N-dimethylformamide (DMF)(3 mL) was stirred in a pwave at 150 °C for 2.5 h. The reaction mixture was purified directly (3injections of ImI DMF) by MDAP (Formic). The appropriate fractions were combined andconcentrated in vacuo to give the product (96 mg, 0.263 mmol, 46percent). LCMS (2 mm Formic): Rt = 1 .00 mi [MH] = 364. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20.60% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 2.5h;Microwave irradiation; | The rac-1 -((2S,3R,4R)-4-amino-2-ethyl-6-fluoro-3-methyl-3,4-dihyd roquinolin- I (2H )-yl)ethanone (for a preparation see Intermediate 40, 100 mg, 0.400 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (98 mg, 0.799mmol), DIPEA (0.140 mL, 0.799 mmol) and N-methyl-2-pyrrolidone (NMP) (2 mL) were placed in a microwaveable vial and irradiated in a microwave at 200 °C for 2.5 h. The reaction was purified directly using a MDAP (Formic) to give a solid, this solid was eluted through a NH2 SPE (5 g) with MeOH, the eluent was concentrated and dried to give the product (29 mg, 0.082 mmol, 20.60percent) as a off white solid. LCMS (2 mm Formic): Rt = 0.96 mi [MH] = 353. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23 mg | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 200℃; for 0.5h;Microwave irradiation; | To a solution of rac- I -((2S,3R,4R)-4-amino-2-ethyl-3-methyl-6-morpholino-3,4-dihydroqu inolin1(2H)-yl)ethanone (for a preparation see Intermediate 73, 40 mg, 0.126 mmol) in N-methyl-2- pyrrolidone (1 .6 mL) was added N,N-diisopropylethylamine (0.066 mL, 0.378 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (30.8 mg, 0.252 mmol). The reaction mixture was heated under microwave conditions, using initial high absorption setting, to 200 °C for 30 mi N-Methyl-2-pyrrolidone (0.3 ml) was added and the solution purified by MDAP (HpH). The solvent was blown down under a stream of nitrogen to give a dark brown gum. The sample was loaded in methanol and purified by aminopropyl SPE (1 g) eluted using methanol. The appropriate fractions were combined and blown down under a stream of nitrogen to give the required product (23 mg) as a yellow gum.LCMS (2 mm HpH): Rt = 0.94 mi [MH] = 420. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With caesium carbonate; In dimethyl sulfoxide; at 25℃; for 16h;Inert atmosphere; | To a magnetically stirred mixture of 6-((2-(2,4-difluorophenyl)oxiran-2- yl)difluoromethyl)pyridin-3-ol (500 mg, 1.671 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (224 mg, 1.838 mmol) in dry DMSO (5.570 mL) was added Cs2C03 (653 mg, 2.005 mmol) in a 20 mL vial under N2 atmosphere. The reaction mixture was stirred at 25 °C for 16 h. The reaction was quenched with water and extracted with Et20 (3x). The combined organic layers were dried by passing through a phase separator and volatiles were removed under a gentle stream of N2. The resulting residue was loaded onto a pad of Celite® and purified by flash chromatography (Si02, 5-30percent EtOAc/Hexanes over 8 min, 30percent for 4 min) to yield the title compound as a colorless oil (667 mg, 99percent): *H NMR (400 MHz, CDC13) delta 8.55 (d, J = 2.2 Hz, 1H), 8.44 (dd, J = 2.3, 0.7 Hz, 1H), 8.00 (dd, J = 8.6, 2.3 Hz, 1H), 7.61 (dd, J = 8.6, 2.5 Hz, 1H), 7.57 (dd, J = 8.6, 0.7 Hz, 1H), 7.41 (dd, J = 14.7, 8.2 Hz, 1H), 7.15 (dd, J = 8.6, 0.7 Hz, 1H), 6.89 - 6.82 (m, 1H), 6.76 (ddd, / = 9.8, 8.9, 2.5 Hz, 1H), 3.47 (d, / = 4.9 Hz, 1H), 3.02 - 2.98 (m, 1H); 19F NMR (376 MHz, CDC13) delta -106.85 (dd, J = 258.0, 8.5 Hz, IF), - 107.45 - - 108.24 (m, 2F), -109.31 (q, J = 8.5 Hz, IF); ESIMS m/z 402 ([M+H]+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.95 g | With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 160℃; for 0.75h;Microwave irradiation; | DIPEA (2.83 mL, 16.22 mmol) was added in a single portion to a stirred solution of (2S,3R,4R)- ethyl 1 -acetyl-4-amino-2,3-dimethyl-1 ,2,3,4-tetrahydroquinoline-6-carboxylate (for a preparation see intermediate 4, 1 .57 g, 5.41 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (1 .320 g, 10.81 mmol) in DMSO (10 mL) at rt. The vial was sealed and then heated in a Biotage Initiator microwave using initial high absorption setting to 160 °C for 45 min. Upon cooling to rt, EtOAc (40 mL) and H20 (40 mL) were added. The separated aqueous phase was extracted with EtOAc (2 x 40 mL). The combined organic phase was passed through a hydrophobic frit and evaporated under reduced pressure to give a brown oil. The oil was loaded in DCM and purified by column chromatography (100 g silica) using a gradient of 0-60percent EtOAc / cyclohexane. The appropriate fractions were combined and evaporated under vacuum to give the product as a white foam (1.95 g). LCMS (2 min Formic): Rt = 1.06 min, [MH]+ = 393. Intermediate 6: (2S.3 4 ?)-1 -acetyl-4-((5-cvanopyridin-2-yl)amino)-2.3-dimethyl-1.2.3.4- tetrahydroquinoline-6-carboxylic acid |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
285 mg | With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; at 160℃; for 0.5h;Microwave irradiation; Sealed tube; | DI PEA (0.384 mL, 2.200 mmol) was added in a single portion to a stirred solution of (2S,4/?)- butyl 1 -acetyl-4-amino-2-methyl-1 ,2,3,4-tetrahydroquinoline-6-carboxylate, hydrochloride (for a preparation see Intermediate 20, 250 mg, 0.733 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (179 mg, 1 .467 mmol) in DMSO (2 mL) at rt. The vial was sealed and then heated in a Biotage Initiator microwave using initial high absorption setting to 160 °C for 30 min. Upon cooling to rt, EtOAc (10 mL) and H20 (10 mL) were added. The separated aqueous phase was extracted with EtOAc (2 x 10 mL). The combined organic phase was passed through a hydrophobic frit and evaporated under reduced pressure to give a brown oil. The sample was loaded in DCM and purified by column chromatography (25 g, silica) using a gradient of 0-40percent EtOAc / cyclohexane. The appropriate fractions were combined and evaporated under vacuum to give the product as a pale yellow oil (285 mg). LCMS (2 min Formic): Rt = 1 .15 min, [MH]+ = 407 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
150 mg | With caesium carbonate; In dimethyl sulfoxide; at 50℃; for 8h; | The (2R, 3R)-2-(2, 5-difluoro-phenyl)-1-(1H-1, 2, 4-triazole-1-yl) butyl -2, 3-diol (1mmol), 2-fluoro-5-cyano pyridine dissolve in dimethyl sulfoxide add cesium carbonate heat the mixture at, 50 °C reaction under the conditions of 8 hours, after the reaction is complete, in reverse into the water, the aqueous phase is extracted with ethyl acetate, the organic phase after turns on lathe does column chromatography preparation to obtain the target product (150 mg). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29.8% | With potassium carbonate; In dimethyl sulfoxide; at 27 - 120℃; | To a solution of (R)-7-(3-(piperazin- l-yl)cyclopent- l-en- l-yl)- l ,6- naphthyridin-5(6H)- one (Compound 34c, 100 mg, 0.337 mmol) in DMSO (5 ml) was added potassium carbonate (280 mg, 2.025 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (53.6 mg, 0.439 mmol) at 27°C. The reaction mixture was stirred at 120°C for 18 hrs. The reaction mixture was poured into ice; the solid thus separated was filtered, washed with water (50 ml) and ether (20 ml). The solid was dissolved in methanol (2 ml) and precipitated with Diethyl ether (20 ml). It was filtered and dried to obtain the title compound (40 mg, 0.100 mmol, 29.8 percent yield) as light brown solid. NMR (400 MHz, DMSO-cfe) delta 11.45 (brs, exchangeable with D20, 1H), 8.90 (d, J = 4.3 Hz, 1H), 8.47 (d, J = 10.4 Hz, 2H), 7.85 (d, J = 9.1 Hz, 1H), 7.48 (t, J = 6.5 Hz, 1H), 6.95 (d, J = 9.9 Hz, 2H), 6.59 (s, 1H), 3.97 - 3.88 (m, 1H), 3.78 - 3.58 (m, 4H), 2.79 - 2.65 (m, 2H), 2.65 - 2.55 (m, 4H), 2.17 - 2.01 (m, 1H), 1.97 - 1.82 (m, 1H). MS: M/Z = 399 (M+l). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | In neat (no solvent); at 180℃; for 5h; | A mixture of 5-bromo-2-(tert-butylthio)aniline (300 mg, 1 .2 mmol) and <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (440 mg, 3.6 mmol) was place in a microwave vial and stirred at 180 °C under neat condition for 5 h before cooled down to room temperature. EtOAc and water were added and the organic layer was washed with brine, dried over Na2S04, concentrated under vacuum and purified on silica gel (5-60percent EtOAc in petroleum ether) to get the title compound (260 mg, 62percent yield) as a yellow solid. LCMS (M+H)+: m/z = 362.09. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | Example 116: 2-(4-chloro-3-fluorophenoxy)-iV-(3-{2-[(5-cyanopyridin-2- yl)oxy]acetamido}bicyclo[l.l.l]pentan-l-yl)acetamide (Compound 215) A mixture of Example 112B (80.2 mg, 0.234 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (51.4 mg, 0.421 mmol), and cesium carbonate (152 mg, 0.468 mmol) in dimethylformamide (4 mL) was stirred for 5 hours. The reaction was quenched with water and brine and extracted with ethyl acetate (twice). The combined organic layers were dried over MgSC>4, filtered, and concentrated. The residue was purified by HPLC (see protocol in Example 112D) to provide the title compound as a trifiuoroacetic acid salt (68.7 mg, 53percent). lH NMR (400 MHz, DMSO- di) delta ppm 8.77 - 8.55 (m, 3H), 8.15 (dd, J = 8.7, 2.3 Hz, 1H), 7.45 (t, J = 8.9 Hz, 1H), 7.04 (ddd, J = 9.7, 6.6, 1.8 Hz, 2H), 6.81 (ddd, J = 8.9, 2.8, 1.2 Hz, 1H), 4.74 (s, 2H), 4.43 (s, 2H), 2.20 (s, 6H). MS (ESI+) m/z 444.9 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With potassium carbonate; In dimethyl sulfoxide; at 130℃; for 3h;Sealed tube; Inert atmosphere; | To a mixture of ( 4aR,6aR6bR8aS,llR, llaR, 11 bR, 13aR 13bR)-4,4,6a,6b,l3bpentamethyl-ll-(prop-l-en-2-yl)icosahydro-lH-cyclopenta[5,6]naphtho[2, lf]isoquinoline-8a-carbaldehyde (25.0 mg, 0.059 mmol), <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (71.7 mg,0.587 mmol) and potassium carbonate (16.23 mg, 0.117 mmol) in a sealed tube wasadded 4 drops ofDMSO. The tube was warmed to l30°C for 3 hours. The reaction mixture was diluted with dichloromethane, washed with water and dried over sodiumsulfate. The drying agent was removed by filtration and the filtrate was concentratedunder reduced pressure. The crude mixture was purified by flash chromatography and thefractions containing product were collected and concentrated in vacuo to give the titlecompound as a white solid (29 mg, 94percent). LC/MS: m/e 528.39 (M+H)+, 3.07 min (method 4B) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 105℃; for 20h;Inert atmosphere; | To a stirred solution of (R)-2-amino-2-phenylethanol (500 mg, 3.64 mmol) in N,N- dimethylformamide (8.0 mL) under an atmosphere of nitrogen was added N,N-diisopropyl-N- ethylamine (9.0 mL, 49 mmol) followed by <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (445 mg, 3.64 mmol). The resulting mixture was heated at 105 °C for 20 h, cooled to ambient temperature, diluted with ethyl acetate (40 mL) and washed with water (10 mL x 3). The ethyl acetate layer was washed with brine (5 mL), dried over anhydrous magnesium sulfate, filtered and evaporated to dryness in vacuo. The crude residue was purified by flash silica gel chromatography (ISCO CombiFlash Rf Purification System®; 40 g SepaFlash® Silica Flash Column, eluting with a 0-100percent ethyl acetate in hexanes gradient) to afford the title compound as a foam. MS (ESI) m/z [M+H]+: 240.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In dimethyl sulfoxide; acetonitrile; at 120℃; for 16h; | A mixture of (1R,2S)-2-phenylcyclohexanamine (300 mg, 1.71 mmol), 6- fluoronicotinonitrile (230 mg, 1.88 mmol) and diisopropylethylamine (0.598 mL, 3.42 mmol) in DMSO (7 mL) was stirred at 120 °C for 16 h. The mixture was cooled to ambient temperature and ACN (3 mL) was added and the mixture was purified by reverse-phase prep-HPLC (preparative HPLC on a GILSON 281 instrument fitted with a Waters XSELECT C18 150x30mmx5um using water and acetonitrile as the eluents. Mobile phase A: water (0.1percentTFA)- ACN, mobile phase B: acetonitrile. Gradient: 40-60percent, 0-10 min; 100percent B, 10.5-12.5min; 5percent B, 13-15min) to give 6-(((1R,2S)-2-phenylcyclohexyl)amino)nicotinonitrile as a solid. MS (ESI) m/z [M+H]+: 278.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 105℃; for 48h;Inert atmosphere; | (0474) To a stirred solution of (S)-tert-butyl 3-phenylpiperazine-1-carboxylate (4.73 g, 18.0 mmol) in N,N-dimethylformamide (41 mL) under an atmosphere of nitrogen was added N,N- diisopropyl-N-ethylamine (9.0 mL, 49 mmol), followed by <strong>[3939-12-6]6-fluoronicotinonitrile</strong> (2.0 g, 16 mmol). The resulting mixture was heated at 105 °C for 48 h, cooled to ambient temperature and quenched with water (300 mL). The mixture was then extracted with ethyl acetate (75 mL x 3) and the combined extracts were washed with water (25 mL x 3), then brine (25 mL), dried over anhydrous magnesium sulfate, filtered and evaporated to dryness in vacuo. The crude residue was purified by flash silica gel chromatography (ISCO CombiFlash Rf Purification System®; 80 g SepaFlash® Silica Flash Column, eluting with a 0-50percent ethyl acetate in hexanes gradient) to afford the title compound as a solid. MS (ESI) m/z [M+H]+: 365.4. |
Tags: 3939-12-6 synthesis path| 3939-12-6 SDS| 3939-12-6 COA| 3939-12-6 purity| 3939-12-6 application| 3939-12-6 NMR| 3939-12-6 COA| 3939-12-6 structure
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.81
[ 205744-17-8 ]
(6-Fluoropyridin-3-yl)methanamine
Similarity: 0.75
[ 39891-05-9 ]
(6-Fluoropyridin-3-yl)methanol
Similarity: 0.73
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.81
[ 42885-14-3 ]
5-Methylpyridine-3-carbonitrile
Similarity: 0.69
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.81
[ 205744-17-8 ]
(6-Fluoropyridin-3-yl)methanamine
Similarity: 0.75
[ 39891-05-9 ]
(6-Fluoropyridin-3-yl)methanol
Similarity: 0.73
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :